top of page

c1.png

  FOX 3C  
CUSTOMER

COMMITMENT
CENTER

 

The VERESCA team at our global FOX 3C headquarters work closely with our distributors technical service staff to bring service excellence in your region personalized for your immediate needs. If there ever is a need to contact us directly, please do so by following the link below.

VERESCA  FOXC1 CUSTOMER COMMITMENT CENTER

VERESCA BLUE WORDMARK CMYK.tif

VERESCA FOXC1 IHC Test
Documentation

Robertos box cosmetic surgery 1.png

Material Safety Data Sheets 

Product Highlights

Package Insert

Instructions for Use

Frequently Asked Questions

Product Patents

Staining Automation

VERESCA FOXC1 Score

VERESCA FOXC1 Score

VERESCA FOXC1 Atlas

VERESCA FOXC1 vs rt-PCR

Evaluating FOXC1 Controls

FOXC1 INTERPRETATION

FOXC1 Prometastatic Cancer Prognosis

Doctor with Files

FOXC1 Poor Prognosis in Breast Cancer

FOXC1 Poor Prognosis in Multiple Cancers (Meta Analysis)

FOXC1 Prognostic Score Report    

Under Development

FOXC1 Poor Prognosis

VERESCA    PRECISION ONCOLOGY

 US | Onconostic Technologies, Inc. 

 EU | 3N Diagnostics Ltd.

Send all correspondence to:

Email: info@FOXC1.email

Tel: +1 (858) 223-3005

PO Box  910163

San Diego, California 92191  USA

®

 © 2023 All rights reserved. 3N Diagnostics Ltd. (NI618099) Murray House, 1 Murray Street, Bellfast, Antrim BT1 6DN, Northern Ireland, United Kingdom

VERESCA and the             logo are trademarks owned by 3N Diagnostics and registered in certain counties.    

Products are protected by patents and pending patents in certain countries.   www.FOXC1.info/patents

* Products approved for In Vitro Diagnostic Use have cleared regulatory review in the European Union and certain countries throughout the globe. Contents herein should not be construed to constitute marketing,  clinical advice or guidance in other jurisdictions.

fox logo pink tm.png
TERMS & CONDITIONS
PRIVACY POLICY
bottom of page